2020
DOI: 10.1016/j.mehy.2020.110066
|View full text |Cite
|
Sign up to set email alerts
|

A hypothesis on the role of the human immune system in covid-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 29 publications
0
11
0
Order By: Relevance
“…145 It has also been suggested that mucus hypersecretion is an underlying cause of hypoxia in COVID-19 patients. 146 Interestingly, PM exposure can suppress mucociliary clearance and promotes mucus hypersecretion, 147,148 although whether effects of PM exposure on mucus production and mucociliary clearance affect SARS-CoV-2 infection and COVID-19 pathogenesis is unclear. Pollutant exposure also decreases levels of various antioxidants in the respiratory tract-lining fluid and tissues, increasing the susceptibility to further oxidative damage mediated by inflammation and/or continued pollutant exposure.…”
Section: How Can Air Pollution Contribute To Sars-cov-2 Infection Andmentioning
confidence: 99%
“…145 It has also been suggested that mucus hypersecretion is an underlying cause of hypoxia in COVID-19 patients. 146 Interestingly, PM exposure can suppress mucociliary clearance and promotes mucus hypersecretion, 147,148 although whether effects of PM exposure on mucus production and mucociliary clearance affect SARS-CoV-2 infection and COVID-19 pathogenesis is unclear. Pollutant exposure also decreases levels of various antioxidants in the respiratory tract-lining fluid and tissues, increasing the susceptibility to further oxidative damage mediated by inflammation and/or continued pollutant exposure.…”
Section: How Can Air Pollution Contribute To Sars-cov-2 Infection Andmentioning
confidence: 99%
“…Numerous studies conclude that the recent coronavirus infection causes an allergic reaction in respiratory tract mucosa, which activates mucin secretion and modulates its chemical structure to enable the virus to enter the cells. [1][2][3] Thereafter, SARS-CoV-2 initiates neutrophil and mucus-mediated inflammatory pathways. 4 SARS-CoV-2 is shed predominantly in upper and lower airway tract secretions.…”
Section: Introductionmentioning
confidence: 99%
“…SARS-Cov-2 hyperstimulate respiratory mucosa through type I hypersensitivity which trigger inflammatory biomarkers. [15] Inflammation triggers neutrophil chemotaxis. Lung-infiltrating neutrophils produce neutrophil extracellular traps (NETs) which increase mucus accumulation and rigidity.…”
Section: Discussionmentioning
confidence: 99%
“…[18] Mucus hypersecretion causes mucus plug formation. [15] Mucous plug can partially or completely obstruct one or more airways, hence should be considered as one of the significant problem in COVID-19 patient as it may worsen shunting and cause desaturation due to further atelectasis and providing suitable environmen bacterial superinfection. [19] Thus bronchoscopy can be considered as therapeutic measures in patients with significant mucous plug formation which is evidenced by infiltrate and/or atelectasis in CXR.…”
Section: Discussionmentioning
confidence: 99%